• ERT and Bioclinica are now Clario. Find out more about our new name, and why we have come together.

Your using an unsupported browser. Please update to a modern browser for a better experience.

Clinical Operations in Oncology Trials West Coast

April 5, 2022
April 6, 2022
PT
Hyatt Regency San Francisco Airport, 1333 Old Bayshore Hwy, Burlingame, CA 94010

The Clinical Operations in Oncology Trials West Coast will offer clinical trial professionals from big and small pharma and biotech’s in the oncology space a much-needed opportunity to uncover new technologies and processes to optimize their clinical and outsourcing operations.

The two day programme will take a holistic approach to the latest challenges and innovations in oncology operations such as end-user-CMO relationships during COVID-19, the evolvement of virtual trials and DTP in oncology trials along with regulatory updates in clinical trials. The conference will also be the platform for innovative case studies and break-out discussions to connect and enhance your knowledge in the oncology space.

Session Information:

Title: Strategies for Successful Oncology Recurrence Trials

Date: Wednesday, April 6, 2022

Time: 11:45 AM PT

This presentation will address successful strategies for oncology recurrence trials including review of operational and read recommendations to help you improve efficiency and quality for your recurrence studies.

Speakers

Dr. Souhil Zaim

VP, Medical and Scientific Affairs, Medical Imaging at Clario

Dr. Zaim is a recognized medical imaging expert in clinical trials with more than 25 years of medical, scientific and industry experience and was most recently chief medical officer at Median Technologies. He is responsible for ensuring the strategic and long-term medical, scientific and technical development of Clario’s Medical and Science Affairs organization in concert with the Medical Imaging Chief Medical Officer, Dr. Michael O’Neal, and Chief Science Officer, Dr. Thomas Fuerst.

Dr. Zaim was previously with Synarc (merged with Bioclinica, now Clario) for more than a decade in various leadership roles, director of radiology services for Europe, medical director, and vice president of radiology. In these roles, Dr. Zaim established and developed global medical and science affairs teams supporting an array of clinical trial indications. Dr. Zaim is regularly published in peer-reviewed journals, and has extensive central reading and adjudication experience encompassing thousands of patients in hundreds of clinical trials in Oncology, Arthritis, Osteoporosis and other areas.

Prior to this, he was assistant professor of Radiology at the University of California at San Francisco. He earned a medical degree from the University of Algiers, Algeria and is board certified in Radiology with a certificate in Magnetic Resonance, both from the University of Paris. Dr. Zaim is a member of the Radiological Society of North America, the European Society of Radiology, and the American Society of Clinical Oncology.